| OHSU # 1455 | Mouse lines for the conditional elimination of the expression of the peripheral benzodiazapine receptor | Michael Forte, Elizabeth Blachly-Dyson, Paolo Bernardi |
| OHSU # 1402 | Flagmor transgenic mouse | John Williams |
| OHSU # 1224 | Murine Model System for Human Cytomegalovirus Latency and Pathogenesis | Jay Nelson, M. Shane Smith, J. Victor Garcia-Martinez, William Fleming, Florence Othieno, Alexis Bailey, Felicia Goodrum |
| OHSU # 1187 | SK3 Floxed Allele Mice (SK3 Null Mice) | John Adelman, Chris Bond, James Maylie |
| OHSU # 0959 | CyP-D Knock-Out Mice | Michael Forte, Paolo Bernardi, Emy Basso |
| OHSU # 0891 B | Small-Conductance CA2+-Activated Potassium Channel 2 (SK2) Transgenic Mice | John Adelman, Chris Bond, James Maylie |
| OHSU # 0891 | Small-Conductance CA2+-Activated Potassium Channel 1 (SK1) Transgenic Mice | John Adelman, Chris Bond, James Maylie |
| OHSU # 0640 | POMC transgenic mice and neuron-specific promoter | Malcolm Low, Marcelo Rubinstein, Flavio Silva de Souza |
| OHSU # 0515 | Small-Conductance Ca2+-Activated Potassium Channel 3 (SK3) transgenic mice | Chris Bond, John Adelman |
| OHSU # 0502 | Melanocortin-3 Receptor Knockout Mice | Roger Cone, Andrew Butler, Robert Kesterson |
| OHSU # 0417 | Pms-2 Knockout Mouse | R. Michael Liskay, C. Eric Bronner, Sean Baker, Yale Univ./Flavell |
| OHSU # 0405 | D2 Dopamine Receptor Knock-Out Mice | Malcolm Low, David Grandy, Marcelo Rubinstein, Michele Kelly |
| OHSU # 0387-B | MC5-R Knockout mice | Malcolm Low, Wenbiao Chen, Roger Cone |
| OHSU # 0379 | D4 Dopamine Receptor Knock-Out Mice | Malcolm Low, David Grandy, Marcelo Rubinstein |
